Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 In Response.Anesthesia and Analgesia.  128:e33. 2019
2018 Do Not Smoke, Eat Healthy, and Exercise.Journal of the American College of Cardiology.  72:2306-2308. 2018
2018 Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality.Neurology.  91:e1741-e1750. 2018
2018 A National Study of U.S. Emergency Departments: Racial Disparities in Hospitalizations for Heart FailureAmerican Journal of Preventive Medicine.  55:S31-S39. 2018
2018 Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.Atherosclerosis.  277:186-194. 2018
2018 PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease.Journal of Clinical Lipidology.  12:835-843. 2018
2018 Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.Circulation: Cardiovascular Quality and Outcomes.  11:e004652. 2018
2018 Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.Journal of the American College of Cardiology.  71:1729-1737. 2018
2018 PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).Circulation.  137:1260-1269. 2018
2018 Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.Journal of Clinical Lipidology.  12:348-355.e2. 2018
2018 Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.Vascular Medicine.  23:232-240. 2018
2018 Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.Circulation.  137:e30-e66. 2018
2018 Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet.  391:205-218. 2018
2018 Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet.  391:219-229. 2018
2018 Cardiac Rehabilitation for Women.Advances in Experimental Medicine and Biology.  1065:565-577. 2018
2017 Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  6. 2017
2017 Age and Sex Disparities in Discharge Statin Prescribing in the Stroke Belt: Evidence From the Reasons for Geographic and Racial Differences in Stroke Study.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  6. 2017
2017 Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.JAMA Cardiology.  2:890-895. 2017
2017 Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs.Circulation.  135:2572-2574. 2017
2017 Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014.Journal of the American College of Cardiology.  69:2696-2706. 2017
2017 Racial differences in statin adherence following hospital discharge for ischemic stroke.Neurology.  88:1839-1848. 2017
2017 Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.JAMA Cardiology.  2:361-369. 2017
2017 Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.Journal of the American College of Cardiology.  69:1386-1395. 2017
2017 Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome Evaluation.American Journal of Medicine.  130:738-743. 2017
2017 Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).PLoS ONE.  12:e0177684. 2017
2017 Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes.American Heart Journal.  183:54-61. 2017
2016 Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?Circulation.  134:1695-1696. 2016
2016 Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE).Menopause.  24:126-132. 2016
2016 Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.Journal of the American College of Cardiology.  68:985-995. 2016
2016 Advanced Imaging and Diagnostic Methods in the Assessment of Suspected Ischemic Heart Disease in Women.Current Cardiology Reports.  18:84. 2016
2016 Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.Journal of Behavioral Medicine.  39:687-693. 2016
2016 Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.American Journal of Medicine.  129:753.e13-753.e22. 2016
2016 Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.Journal of Women's Health.  25:875-881. 2016
2016 Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination.ESC Heart Failure.  3:11-17. 2016
2016 Managing Residual Risk After Myocardial Infarction Among Individuals with Low Cholesterol Levels.Endocrinology and Metabolism Clinics of North America.  45:171-184. 2016
2016 Statins and Cognitive Side Effects: What Cardiologists Need to Know.Endocrinology and Metabolism Clinics of North America.  45:101-116. 2016
2016 The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials.Thromb Haemost.  115:520-532. 2016
2016 Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study.Menopause.  23:150-157. 2016
2016 Tree-based identification of subgroups for time-varying covariate survival data.Statistical Methods in Medical Research.  25:488-501. 2016
2016 Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.Circulation.  133:256-264. 2016
2016 Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.Scientific Reports.  6:30060. 2016
2015 Selecting Patients for Statin Therapy in Primary Prevention: If We Could Only Predict the Future.Journal of the American College of Cardiology.  66:2710-2712. 2015
2015 The role of the clinical pharmacist in the care of patients with cardiovascular disease.Journal of the American College of Cardiology.  66:2129-2139. 2015
2015 The Association Between Life-Space and Health Care Utilization in Older Adults with Heart Failure.Journals of Gerontology, Series A.  70:1442-1447. 2015
2015 Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.Journal of the American College of Cardiology.  66:1864-1872. 2015
2015 Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.Thromb Haemost.  114:546-557. 2015
2015 Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.Journal of the American College of Cardiology.  66:765-773. 2015
2015 Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009.American Heart Journal.  170:249-255. 2015
2015 Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking.Circulation: Heart Failure.  8:694-701. 2015
2015 Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation: Challenges and Opportunities.Journal of the American College of Cardiology.  65:2652-2659. 2015
2015 The National Physical Activity Plan: a call to action from the American Heart Association: a science advisory from the American Heart Association.Circulation.  131:1932-1940. 2015
2015 ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3): A Report of the ACC Competency Management CommitteeJournal of the American College of Cardiology.  65:1721-1723. 2015
2015 COCATS 4 Task Force 2: Training in Preventive Cardiovascular Medicine.Journal of the American College of Cardiology.  65:1754-1762. 2015
2015 Managing residual risk after myocardial infarction among individuals with low cholesterol levels.Cardiology Clinics.  33:299-308. 2015
2015 Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training.Circulation: Heart Failure.  8:497-503. 2015
2015 Statins and cognitive side effects: what cardiologists need to know.Cardiology Clinics.  33:245-256. 2015
2015 Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults ≥65 years with heart failure.American Journal of Cardiology.  115:797-801. 2015
2015 Relationship of Physical Activity and Healthy Eating with Mortality and Incident Heart Failure among Community-Dwelling Older Adults with Normal Body Mass Index.ESC Heart Failure.  2:20-24. 2015
2015 Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.American Journal of Cardiology.  115:447-453. 2015
2015 Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  4. 2015
2015 Chest pain characteristics and gender in the early diagnosis of acute myocardial infarction.Current Cardiology Reports.  17:5. 2015
2015 Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.Journal of the American College of Cardiology.  65:270-277. 2015
2015 Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.International Journal of Cardiology.  178:111-116. 2015
2015 Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary eventAmerican Journal of Cardiology.  114:826-831. 2015
2015 Familial hypercholesterolemia--epidemiology, diagnosis, and screening.Current Atherosclerosis Reports.  17:482. 2015
2015 Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial.International Journal of Endocrinology.  2015:610239. 2015
2014 Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.American Heart Journal.  168:682-689. 2014
2014 JCL roundtable: lipid-lowering drugs in those older than 75 years of age.Journal of Clinical Lipidology.  8:533-541. 2014
2014 New ACC-AHA cholesterol guidelines significantly increase potential eligibility for statin treatment.Evidence Based Medicine.  19:198. 2014
2014 Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.American Journal of Cardiology.  114:826-831. 2014
2014 Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia.American Journal of Medicine.  127:840-847. 2014
2014 Lipid-lowering therapy in patients 75 years and older: clinical priority or superfluous therapy?Progress in Cardiovascular Diseases.  57:187-196. 2014
2014 Functional status and outcome after coronary artery bypass grafting.JACC: Heart Failure.  2:344-346. 2014
2014 Left anterior descending coronary artery occlusion secondary to metastatic squamous cell carcinoma presenting as ST-segment-elevation myocardial infarction.Circulation.  129:e652-e653. 2014
2014 Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease.International Journal of Cardiology.  174:436-439. 2014
2014 An assessment by the Statin Cognitive Safety Task Force: 2014 update.Journal of Clinical Lipidology.  8:S5-16. 2014
2014 Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).Journal of the American College of Cardiology.  63:1626-1633. 2014
2014 Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study.BMC Health Services Research.  14:195. 2014
2014 Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes of Exercise TraiNing) by sex.JACC: Heart Failure.  2:180-186. 2014
2014 Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  3:e000660. 2014
2014 Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults.Journal of Clinical Lipidology.  8:86-93. 2014
2013 Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.Circulation.  128:2422-2446. 2013
2013 Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.International Journal of Cardiology.  168:2335-2340. 2013
2013 Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events.International Journal of Cardiology.  168:1905-1909. 2013
2013 Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.Journal of Women's Health.  22:724-732. 2013
2013 Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.Women's Health.  9:479-490. 2013
2013 Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).American Heart Journal.  166:488-495. 2013
2013 Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.American Journal of Cardiology.  112:664-670. 2013
2013 Exercise standards for testing and training: a scientific statement from the American Heart Association.Circulation.  128:873-934. 2013
2013 Retraction notice to "Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease" [Am Heart J 2012;164:387-393].American Heart Journal.  166:197. 2013
2013 Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.Cardiovascular diagnosis and therapy.  3:64-72. 2013
2013 Reply: To PMID 23177293.Journal of the American College of Cardiology.  61:2113. 2013
2013 Risk factor control for coronary artery disease secondary prevention in large randomized trials.Journal of the American College of Cardiology.  61:1607-1615. 2013
2013 LDL Lowering After Acute Coronary Syndrome: Is Lower Better?Current Treatment Options in Cardiovascular Medicine.  15:33-40. 2013
2012 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure.Journal of the American College of Cardiology.  60:2653-2661. 2012
2012 Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: a statement for health care professionals from the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association.Circulation.  126:2535-2543. 2012
2012 Association of race and sex with risk of incident acute coronary heart disease events.Journal of the American Medical Association.  308:1768-1774. 2012
2012 Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: a statement for health care professionals from the American Association for Cardiovascular and Pulmonary Rehabilitation and the American Heart Association.Journal of Cardiopulmonary Rehabilitation.  32:410-419. 2012
2012 Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association.Circulation.  126:1514-1563. 2012
2012 Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease.American Heart Journal.  164:387-393. 2012
2012 Cardiac rehabilitation: call to action for healthcare providers.Circulation.  126:671-673. 2012
2012 Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation study.Psychosomatic Medicine.  74:263-270. 2012
2012 Increasing referral and participation rates to outpatient cardiac rehabilitation: the valuable role of healthcare professionals in the inpatient and home health settings: a science advisory from the American Heart Association.Circulation.  125:1321-1329. 2012
2012 Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women.Journal of Women's Health.  21:133-139. 2012
2011 Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association.Circulation.  124:2951-2960. 2011
2011 Cardiac rehabilitation outcomes: impact of comorbidities and age.Journal of Cardiopulmonary Rehabilitation.  31:342-348. 2011
2011 Isolated diastolic hypotension and incident heart failure in older adults.Hypertension.  58:895-901. 2011
2011 Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data.BMJ.  343:d5170. 2011
2011 Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.Journal of Clinical Lipidology.  5:338-367. 2011
2011 Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.Menopause.  18:943-950. 2011
2011 Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.Circulation.  123:2292-2333. 2011
2011 Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women.International Journal of Cardiology.  148:36-42. 2011
2011 Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial).American Journal of Cardiology.  107:980-985. 2011
2011 Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.American Journal of Cardiology.  107:898-905. 2011
2011 DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Obstetrical and Gynecological Survey.  66:143-144. 2011
2010 DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).Journal of Clinical Endocrinology and Metabolism.  95:4985-4992. 2010
2010 Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.JACC: Cardiovascular Imaging.  3:1030-1036. 2010
2010 Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women.Journal of Clinical Lipidology.  4:324-334. 2010
2010 The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.Journal of Clinical Endocrinology and Metabolism.  95:4432-4440. 2010
2010 Exercise as a treatment for the risk of cardiovascular disease.Current Treatment Options in Cardiovascular Medicine.  12:329-341. 2010
2010 Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.Psychosomatic Medicine.  72:549-555. 2010
2010 Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).American Journal of Cardiology.  105:905-911. 2010
2010 Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.American Heart Journal.  159:385-391. 2010
2010 Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.Circulation.  121:252-258. 2010
2010 Cardiac rehabilitation and women: what keeps them away?Journal of Cardiopulmonary Rehabilitation.  30:12-21. 2010
2009 Menopause, age, and cardiovascular risk: a complex relationship.Journal of the American College of Cardiology.  54:2374-2375. 2009
2009 Biomarkers of atherosclerosis: Clinical applicationsCurrent Cardiovascular Risk Reports.  3:23-30. 2009
2009 Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study.British heart journal.  95:1901-1906. 2009
2009 Assessing patient recall of discharge instructions for acute myocardial infarction.Journal for Healthcare Quality.  31:25-33. 2009
2009 Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.Psychosomatic Medicine.  71:958-964. 2009
2009 Baseline differences in the HF-ACTION trial by sex.American Heart Journal.  158:S16-S23. 2009
2009 ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.Journal of the American College of Cardiology.  54:1364-1405. 2009
2009 AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.Circulation.  120:1296-1336. 2009
2009 Postmenopausal hormone therapy and the risk of cardiovascular disease.Expert Opinion on Pharmacotherapy.  10:2041-2053. 2009
2009 Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).Journal of Women's Health.  18:1315-1322. 2009
2009 Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program.Journal of the American College of Cardiology.  54:515-521. 2009
2009 Comparison of baseline characteristics and outcomes in younger and older patients completing cardiac rehabilitation.Journal of Cardiopulmonary Rehabilitation.  29:220-229. 2009
2009 Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.Archives of General Psychiatry.  66:499-507. 2009
2009 The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study.Journal of Women's Health.  18:443-450. 2009
2009 The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE).American Heart Journal.  157:548-555. 2009
2009 The TNT study, women and cancerBritish heart journal.  95:250. 2009
2009 Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study.Journal of the American College of Cardiology.  53:176-183. 2009
2009 Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Preventive Cardiology.  12:9-18. 2009
2009 Drugs are not enough: the metabolic syndrome--a call for intensive therapeutic lifestyle change.Journal of the CardioMetabolic Syndrome.  4:20-25. 2009
2008 Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study).American Journal of Cardiology.  102:1312-1317. 2008
2008 Biomarkers of atherosclerosis: clinical applications.Current Cardiology Reports.  10:497-504. 2008
2008 Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.Journal of Clinical Endocrinology and Metabolism.  93:4268-4275. 2008
2008 Health-related quality of life following coronary artery bypass graft surgery in post-menopausal women.Journal of General Internal Medicine.  23:1429-1434. 2008
2008 Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).Journal of Women's Health.  17:1081-1092. 2008
2008 Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.Mayo Clinic Proceedings.  83:870-879. 2008
2008 Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study).American Journal of Cardiology.  102:150-154. 2008
2008 Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?Journal of Women's Health.  17:841-847. 2008
2008 ReplyJournal of the American College of Cardiology.  51:1991. 2008
2008 Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.Journal of the American College of Cardiology.  51:1448-1454. 2008
2008 A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in womenSouthern Medical Journal.  101:339-340. 2008
2008 Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.British heart journal.  94:434-439. 2008
2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.Journal of Clinical Endocrinology and Metabolism.  93:1276-1284. 2008
2008 Social networks and incident stroke among women with suspected myocardial ischemia.Psychosomatic Medicine.  70:282-287. 2008
2008 Angina pectoris: reversal of the gender gap.Circulation.  117:1505-1507. 2008
2008 Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.Journal of Translational Medicine.  6:11. 2008
2008 Task force 10: training in preventive cardiovascular medicine.Journal of the American College of Cardiology.  51:393-398. 2008
2008 Depression, the metabolic syndrome and cardiovascular risk.Psychosomatic Medicine.  70:40-48. 2008
2008 Racial differences of lipoprotein subclass distributions in postmenopausal women.Ethnicity and Disease.  18:176-180. 2008
2007 Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.Journal of Clinical Lipidology.  1:564-574. 2007
2007 Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study.Journal of the American College of Cardiology.  50:2044-2050. 2007
2007 Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.Clinical Journal of the American Society of Nephrology.  2:1131-1139. 2007
2007 Post-challenge glucose predicts coronary atherosclerotic progression in non-diabetic, post-menopausal women.Diabetic Medicine.  24:1156-1159. 2007
2007 Transthoracic echocardiography guided procedures in the catheterization laboratory.Echocardiography.  24:1000-1007. 2007
2007 HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.New England Journal of Medicine.  357:1301-1310. 2007
2007 Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.Circulation.  116:572-584. 2007
2007 Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.Annals of Internal Medicine.  147:1-9. 2007
2007 Influenza vaccination in secondary prevention: an opportunity missed.Journal of Cardiopulmonary Rehabilitation.  27:202-207. 2007
2007 Secondary prevention outcomes among black and white cardiac rehabilitation patients.American Heart Journal.  153:980-986. 2007
2007 Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.Circulation.  115:2675-2682. 2007
2007 Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.Journal of Cardiopulmonary Rehabilitation.  27:121-129. 2007
2007 Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.Journal of Women's Health.  16:228-234. 2007
2007 Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.Circulation.  115:576-583. 2007
2007 Outcomes at one-year follow-up of women and men with coronary artery disease discharged from cardiac rehabilitation: what benefits are maintained?Journal of Cardiopulmonary Rehabilitation.  27:11-18. 2007
2006 Perspectives on dyslipidemia and coronary heart disease in women: an update.Current Opinion in Cardiology.  21:602-607. 2006
2006 Self-rated health among women with coronary disease: depression is as important as recent cardiovascular events.American Heart Journal.  152:921.e1-921.e7. 2006
2006 Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study.Journal of Women's Health.  15:836-842. 2006
2006 The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.Circulation.  114:894-904. 2006
2006 Migraines, angiographic coronary artery disease and cardiovascular outcomes in women.American Journal of Medicine.  119:670-675. 2006
2006 Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study.American Heart Journal.  152:126-135. 2006
2006 Menopause: Cause of consequenceACC Cardiosource Review Journal.  15:84-85. 2006
2006 Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study.European Heart Journal.  27:1408-1415. 2006
2006 Phytoestrogens and lipoproteins in women.Journal of Clinical Endocrinology and Metabolism.  91:2209-2213. 2006
2006 Menopause and cardiovascular risk cause or consequence?Journal of the American College of Cardiology.  47:1984-1986. 2006
2006 Cardiac rehabilitation as secondary prevention center.Coronary Artery Disease.  17:211-218. 2006
2006 Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.Fertility and Sterility.  85:1425-1431. 2006
2006 Practical interpretation of 6-minute walk data using healthy adult reference equations.Journal of Cardiopulmonary Rehabilitation.  26:167-171. 2006
2006 Training community health workers to reduce health disparities in Alabama's Black Belt: the Pine Apple Heart Disease and Stroke Project.Family and Community Health.  29:89-102. 2006
2006 Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study.Journal of the American College of Cardiology.  47:S50-S58. 2006
2006 Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.Journal of the American College of Cardiology.  47:S4-S20. 2006
2006 Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.Journal of the American College of Cardiology.  47:S21-S29. 2006
2006 The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).Annals of Epidemiology.  16:138-145. 2006
2005 Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation.American Heart Journal.  150:1140-1146. 2005
2005 Perspectives on dyslipidemia and coronary heart disease in women.Journal of the American College of Cardiology.  46:1628-1635. 2005
2005 Women in cardiac rehabilitation: outcomes and identifying risk for dropout.American Heart Journal.  150:1052-1058. 2005
2005 Dietitian services are associated with improved patient outcomes and the MEDFICTS dietary assessment questionnaire is a suitable outcome measure in cardiac rehabilitation.Journal of The American Dietetic Association.  105:1533-1540. 2005
2005 Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.Annals of Internal Medicine.  142:813-820. 2005
2005 Depression and heart failure in patients with a new myocardial infarction.American Heart Journal.  149:851-855. 2005
2004 Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.Journal of Women's Health.  13:872-887. 2004
2004 Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: the Women's Angiographic Vitamin & Estrogen Trial.American Heart Journal.  148:293-299. 2004
2004 Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B.American Journal of Cardiology.  94:219-222. 2004
2004 The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.Diabetes Care.  27:925-930. 2004
2004 Knowledge of heart attack symptoms in 20 US communities. Results from the Rapid Early Action for Coronary Treatment Community Trial.Preventive Medicine.  38:85-93. 2004
2004 Non-high-density lipoprotein cholesterol: an alternate target for lipid-lowering therapy.Preventive Cardiology.  7:122-126. 2004
2004 Optimizing risk stratification in cardiac rehabilitation with inclusion of a comorbidity index.Journal of Cardiopulmonary Rehabilitation.  24:8-13. 2004
2003 Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).American Heart Journal.  146:870-875. 2003
2003 Personal, social, and physical environmental correlates of physical activity in rural African-American women in Alabama.American Journal of Preventive Medicine.  25:30-37. 2003
2003 Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial.American Heart Journal.  146:439-445. 2003
2003 Non-high-density lipoprotein cholesterol and cardiovascular diseaseCurrent Opinion in Lipidology.  14:367-371. 2003
2003 Non-high-density lipoprotein cholesterol and cardiovascular disease.Current Opinion in Lipidology.  14:367-371. 2003
2003 Exercise testing in heart failure: maximal, submaximal, or both?Journal of the American College of Cardiology.  42:123-125. 2003
2003 Factors associated with the failure of patients to complete cardiac rehabilitation for medical and nonmedical reasons.Journal of Cardiopulmonary Rehabilitation.  23:281-289. 2003
2003 Physical activity patterns among women in rural Alabama.Health values.  27:311-321. 2003
2003 The 6-minute walk test: how important is the learning effect?American Heart Journal.  146:129-133. 2003
2003 Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized control trialEvidence Based Eye Care.  4:82-83. 2003
2003 Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study.Journal of the American College of Cardiology.  41:413-419. 2003
2003 The 6-min walk test: a quick measure of functional status in elderly adults.Chest.  123:387-398. 2003
2003 Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.Annals of Internal Medicine.  138:1-9. 2003
2003 Hormone replacement therapy did not reduce the risk of cardiovascular events or non-cardiovascular disease outcomes in postmenopausal women in CHDEvidence-based Obstetrics and Gynecology.  5:51-52. 2003
2003 Personal, social, and physical environmental correlates of physical activity in rural African-American women in AlabamaAmerican Journal of Preventive Medicine.  25:30-37. 2003
2003 Women in cardiac rehabilitation.Journal of the American Medical Women's Association.  58:227-235. 2003
2002 Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE).American Journal of Medicine.  113:723-727. 2002
2002 Women and coronary heart disease risk factors.Journal of cardiovascular risk.  9:315-322. 2002
2002 Women's angiographic vitamin and estrogen trial: design and methods.Controlled Clinical Trials.  23:708-727. 2002
2002 Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.Journal of the American Medical Association.  288:2432-2440. 2002
2002 Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).Circulation.  106:2537-2542. 2002
2002 Lipoprotein abnormalities related to women's healthAmerican Journal of Cardiology.  90:77-84. 2002
2002 Lipoprotein abnormalities related to women's health.American Journal of Cardiology.  90:77i-84i. 2002
2002 Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).Journal of the American Medical Association.  288:49-57. 2002
2002 ATS statement: guidelines for the six-minute walk test.American Journal of Respiratory and Critical Care Medicine.  166:111-117. 2002
2002 Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease.Heart & Lung: The Journal of Acute and Critical Care.  31:262-270. 2002
2002 Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).Circulation.  105:2962-2967. 2002
2002 Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.Arteriosclerosis, Thrombosis, and Vascular Biology.  22:1012-1017. 2002
2002 Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.Circulation.  105:2253-2258. 2002
2002 Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study.Journal of the American Geriatrics Society.  50:416-423. 2002
2002 Hormone treatment - Misconceptions and agreements [4] (multiple letters)European Heart Journal.  23:89-91. 2002
2002 Hormone treatment--misconceptions and agreements.European Heart Journal.  23:89-91. 2002
2002 Lipid management in elderly patients: Clinical challenges and therapeutic strategiesAnnals of Long-Term Care.  10:21-24. 2002
2002 Prehospital delay in individuals with acute coronary disease: concordance of medical records and follow-up phone interviews.Cardiology.  97:159-165. 2002
2002 Women and coronary heart disease risk factorsJournal of cardiovascular risk.  9:315-322. 2002
2001 Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design.Psychosomatic Medicine.  63:747-755. 2001
2001 Treatment of dyslipidemia in pre- and postmenopausal women with and without known atherosclerotic cardiovascular disease.Current Cardiology Reports.  3:401-407. 2001
2001 Assessment of functional outcomes using the 6-minute walk test in cardiac rehabilitation: comparison of patients with and without left ventricular dysfunction.Journal of Cardiopulmonary Rehabilitation.  21:221-224. 2001
2001 Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.Diabetes Care.  24:1233-1239. 2001
2001 Estrogens, lipids and cardiovascular disease: no easy answers.Journal of the American College of Cardiology.  37:431-433. 2001
2000 Advance directives in cardiac and pulmonary rehabilitation patients.Journal of Cardiopulmonary Rehabilitation.  20:340-345. 2000
2000 Weight cycling and high-density lipoprotein cholesterol in women: Evidence of an adverse effect. A report from the NHLBI-sponsored WISE studyJournal of the American College of Cardiology.  36:1565-1571. 2000
2000 Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group.Journal of the American College of Cardiology.  36:1565-1571. 2000
2000 Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study.Journal of Womens Health and Gender Based Medicine.  9:769-777. 2000
2000 Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group.Academic Emergency Medicine.  7:862-872. 2000
2000 Age and sex differences in presentation of symptoms among patients with acute coronary disease: The REACT trialCoronary Artery Disease.  11:399-407. 2000
2000 Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial. Rapid Early Action for Coronary Treatment.Coronary Artery Disease.  11:399-407. 2000
2000 Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.American Heart Journal.  139:1081-1087. 2000
2000 Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators.American Journal of Cardiology.  85:1083-1088. 2000
2000 Correlates of high HDL cholesterol among women with coronary heart disease.American Heart Journal.  139:288-296. 2000
2000 Correlates of high hdl cholesterol among women with coronary heart diseaseAmerican Heart Journal.  139:288-296. 2000
2000 Hormone replacement therapy in clinical cardiology.Cardiology in Review.  8:57-64. 2000
1999 Determining prognosis in congestive heart failure: role of the 6-minute walk test.American Heart Journal.  138:593-596. 1999
1999 Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997.Diabetes Care.  22:736-742. 1999
1999 Women versus men regarding outcome of CABG or PTCA.Circulation.  99:1925-1926. 1999
1999 Referral patterns to a University-based cardiac rehabilitation program.American Journal of Cardiology.  83:252-A5. 1999
1999 Determining prognosis in congestive heart failure: Role of the 6-minute walk testAmerican Heart Journal.  138:593-596. 1999
1998 Knowledge of heart attack symptoms in a population survey in the United States: The REACT Trial. Rapid Early Action for Coronary Treatment.Archives of Internal Medicine -New Series-.  158:2329-2338. 1998
1998 Knowledge of heart attack symptoms in a population survey in the United States: The REACT trialArchives of Internal Medicine -New Series-.  158:2329-2338. 1998
1998 [Predictors of readmission in patients with congestive heart failure].Revista Médica de Chile.  126:1173-1181. 1998
1998 Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI)Circulation.  98:1279-1285. 1998
1998 Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collection.Controlled Clinical Trials.  19:391-403. 1998
1998 Atherosclerosis and the immune system.Archives of Internal Medicine -New Series-.  158:1395-1396. 1998
1998 Implications of coronary artery disease plus lower-extremity arterial disease for diabeticsCardiology in Review.  15:22-28. 1998
1998 Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the Coronary Artery Surgery Study Registry.American Heart Journal.  135:1055-1062. 1998
1998 Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the coronary artery surgery study registryAmerican Heart Journal.  135:1055-1062. 1998
1997 Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)American Journal of Cardiology.  80:1395-1401. 1997
1997 Coronary artery disease in diabetic patients with lower-extremity arterial disease: disease characteristics and survival. A report from the Coronary Artery Surgery Study (CASS) registry.Diabetes Care.  20:1381-1387. 1997
1997 Six-minute walk test in patients with cardiac dysfunction.Cardiologia -Roma-.  42:897-902. 1997
1997 Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.Journal of the American Medical Association.  277:1281-1286. 1997
1996 Platelet activation and restenosis after coronary stenting: flow cytometric detection of wound-induced platelet activation.Coronary Artery Disease.  7:657-665. 1996
1996 Factors limiting the enrollment of women in a randomized coronary artery disease trial. The Asymptomatic Cardiac Ischemia Pilot Study (ACIP) Investigators.Clinical Cardiology.  19:614-618. 1996
1996 Factors limiting the enrollment of women in a randomized coronary artery disease trialClinical Cardiology.  19:614-618. 1996
1995 Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study.Journal of the American College of Cardiology.  25:1000-1009. 1995
1995 Hypertension in women.Current Opinion in Nephrology and Hypertension.  4:204-207. 1995
1994 Hormonal treatment of postmenopausal women.New England Journal of Medicine.  331:550. 1994
1994 Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry).American Journal of Cardiology.  74:334-339. 1994
1994 Primary and secondary prevention of ischemic heart disease.Current Opinion in Cardiology.  9:417-427. 1994
1994 Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.Journal of the American College of Cardiology.  23:1410-1420. 1994
1994 In Reply: The Predictive Capabilities of Clinical Tests: The 6-Minute WalkJournal of the American Medical Association.  271:662. 1994
1994 Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.Journal of the American College of Cardiology.  23:393-400. 1994
1994 Atherogenicity of postprandial lipoproteins and coronary heart diseaseEndocrinologist.  4:359-372. 1994
1993 Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular DysfunctionJournal of the American Medical Association.  270:1702-1707. 1993
1993 Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators.Journal of the American Medical Association.  270:1702-1707. 1993
1993 Efficacy studies in coronary rehabilitation.Cardiology Clinics.  11:333-347. 1993
1992 Frequency of stress-induced thallium-201 defects in patients with patent internal mammary artery to the left anterior descending coronary artery graft.American Journal of Cardiology.  70:399-400. 1992
1992 Renal, hemodynamic, and electrocardiographic effects of low versus high osmolality contrast agents on the transplanted heart.The Journal of heart transplantation.  11:584-586. 1992
1992 Renal, hemodynamic, and electrocardiographic effects of low versus high osmolality contrast agents on the transplanted heartThe Journal of heart transplantation.  11:584-586. 1992
1991 31P NMR spectroscopy in chronic adriamycin cardiotoxicity.Magnetic Resonance in Medicine.  17:69-81. 1991
1989 Nuclear magnetic resonance imaging of the cardiovascular systemCurrent Opinion in Cardiology.  4:845-852. 1989
1989 The value of cine nuclear magnetic resonance imaging for assessing regional ventricular function.Journal of the American College of Cardiology.  14:1721-1729. 1989
1989 Overview of cardiovascular nuclear magnetic resonance imaging.Cardiology Clinics.  7:631-649. 1989
1989 Dual connection of the left anterior descending coronary artery to the left and right coronary arteries.Catheterization and cardiovascular diagnosis.  16:168-172. 1989
1988 Cardiac matrix alterations induced by adriamycin.American Journal of Pathology.  133:298-305. 1988
1988 Atrial septal defect in older adults: atypical radiographic appearances.Radiology.  167:123-127. 1988

Investigator On

  • Private Grant  awarded by DALCOR PHARMA UK LTD 2016 - 2024
  • Private Grant  awarded by AMGEN, INC. 2012 - 2020
  • Private Grant  awarded by AMGEN, INC. 2018 - 2019
  • Private Grant  awarded by Sanofi US Services Inc 2013 - 2019
  • Private Grant  awarded by AMGEN, INC. 2017 - 2018
  • Private Grant  awarded by AMGEN, INC. 2016 - 2018
  • Nurse Education, Practice, Quality and Retention (NEPQR) Program - Interprofessional Collaborative Practice  awarded by Health Resources and Services Administration/DHHS 2014 - 2018
  • Private Grant  awarded by AMGEN, INC. 2011 - 2017
  • Private Grant  awarded by AMGEN, INC. 2013 - 2017
  • Private Grant  awarded by AMGEN, INC. 2015 - 2016
  • Private Grant  awarded by ELI LILLY AND COMPANY 2012 - 2016
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • PEGASUS:A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on Background of Acetyl Salicylic Acid (ASA) Therapy in Patients with History of Myocardial Infarction  awarded by Brigham and Women's Hospital 2011 - 2015
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2005 - 2015
  • SOLID TIMI 52: Stabilization of Plaques Using Darapladib--A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events  awarded by Brigham and Women's Hospital 2010 - 2014
  • Private Grant  awarded by AMGEN, INC. 2013 - 2014
  • Private Grant  awarded by AMGEN, INC. 2012 - 2014
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2010 - 2014
  • Social Support, Self-Management, and Hospital Use for Heart Failure  awarded by American Heart Association 2008 - 2013
  • Private Grant  awarded by AMGEN, INC. 2012 - 2013
  • HPS 3/TIMI 55-Reveal (Randomized Evaluation of the Effects of Anacetrapib through Lipid-Modification)  awarded by Brigham and Women's Hospital 2011 - 2012
  • Pretreatment Genotyping at APOA5 and GCKR Loci and Response to Fenofibrate Therapy  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2009 - 2012
  • Private Grant  awarded by Genentech 2012
  • Education And Training

  • Doctor of Medicine, University of South Alabama
  • Full Name

  • Vera Bittner
  • Blazerid

  • vbittner